UnknownNot Applicable

Effect of Laser Puncture Versus Ultraviolet Radiation on Women With Polycystic Ovarian Syndrome

Egypt100 participantsStarted 2023-08-30

Plain-language summary

Obese women with polycystic ovarian syndrome aged between 25 and 35 years old will be divided into three groups. For three months, group (A) will receive laser puncture (3 sessions per week), along with a metformin supplementation, group (B) will receive ultraviolet radiation (3 sessions per week), along with a metformin supplementation, while group (C) will receive only metformin supplementation. The follicular size will be measured using ultrasound, while, female sex hormones, and serum 25-hydroxyvitamin D levels will bel evaluated using blood analysis

Who can participate

Age range20 Years – 35 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Obese nulli gravid PCOS women * BMI 30-40 kg/m2 Exclusion Criteria: * hyperprolactinemia * BMI \> 40 kg/m2 Endocrinological disorders such as thyroid disease, Cushing's syndrome, Coagulopathy * Recent use of oral contraceptive pills * Recent use of any photosensitizing medications, such as aspirin, tetracycline, chlorothiazide, or psoralen suspicious of neoplasms

What they're measuring

LH/FSH ratio

Timeframe: 1 month after treatment

Trial details

NCT IDNCT05986838

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02

Contact for this trial

Ahmed M Maged

+201005227404 Ahmedmaged@cu.edu.eg

View on ClinicalTrials.gov More Polycystic Ovary Syndrome trials